Inventor
Stevan W. Djuric
Inventor
Libertyville, IL, US
Overview
Patents· 69 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds40%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations28%
C07CAcyclic or carbocyclic compounds16%
A61KPreparations for medical, dental or toiletry purposes7%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium4%
C07HSugars3%
Y02EReduction of greenhouse gas [ghg] emissions, related to energy generation, transmission or distribution2%
C07BGeneral methods of organic chemistry1%
Y02PClimate change mitigation technologies in the production or processing of goods1%
PatentTitleYear
10,266,532Tricyclic modulators of TNF signaling20199,879,033'Modulators of 5-HT receptors and methods of use thereof'20189,701,679'Modulators of 5-HT receptors and methods of use thereof'20179,656,955'Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy'20179,650,334'Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy'20179,187,483'Modulators of 5-HT receptors and methods of use thereof'20159,163,007'5-substituted indazoles as kinase inhibitors'20158,846,951'Modulators of 5-HT receptors and methods of use thereof'20148,846,663'Modulators of 5-HT receptors and methods of use thereof'20148,648,069'5-substituted indazoles as kinase inhibitors'20148,637,546'Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DDP-IV)'20148,546,377'Modulators of 5-HT receptors and methods of use thereof'20138,518,933'Modulators of 5-HT receptors and methods of use thereof'20138,119,664'Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)'20127,956,185'Cyclobut-3-ene-1,2,-dione inhibitors of polo-like kinases'20117,795,248'Substituted 7,8-dihydro-1H-pyrimido[4,5-B][1,4]diazepin-4-amines are novel kinase inhibitors'20107,671,076'Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)'20107,468,371'Tricyclic pyrazole kinase inhibitors'20087,348,346'Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)'20087,329,675'Substituted azabicyclic compounds'20087,262,207'Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)'20077,238,724'Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)'20076,998,390'Oxolide antibacterials'20066,933,283'11-deoxy azalide antibacterials'20056,831,068'Macrolide antibacterial compounds'20046,800,645'Substituted azabicyclic compounds'20046,667,338'9-amino erythromycin derivatives with antibacterial activity'20036,506,876'LTA4 hydrolase inhibitor pharmaceutical compositions and methods of use'20036,410,728'Oxazolidinone chemotherapeutic agents'20026,303,600'Substituted azabicyclic compounds'20016,277,868'Oxazolidinone chemotherapeutic agents'20016,057,369'Substituted (aryl, heteroaryl, arylmethyl or heteroarylmethyl) hydroxamic acid compounds'20005,990,326'3-oxiranyl benzoic acids and derivatives thereof'19995,723,492'LTA4 hydrolase inhibitor pharmaceutical compositions and methods of use'19985,719,306'LTA.sub.4 hydrolase inhibitors'19985,684,162'Leukotriene B.sub.4 antagonists'19975,591,756'LTB4 synthesis inhibitors'19975,585,492'LTA.sub.4 Hydrolase inhibitors'19965,578,619'Alkoxy-substituted dihydrobenzopyran-2-sulfonimides'19965,532,383'Leukotriene B.sub.4 antagonists'19965,508,309'LTB4 synthesis inhibitors'19965,439,937'Leukotriene B.sub.4 antagonists'19955,380,740'Anti-inflammatory compounds, compositions and method of use thereof'19955,356,919'Leukotriene B.sub.4 synthesis inhibitors'19945,310,951'Leukotriene B.sub.4 antagonists'19945,217,981'LTB4 synthesis inhibitors'19935,212,198'Alkoxy-substituted dihydrobenzopyran-2-carboxylic acids and derivatives thereof'19935,192,782'Alkoxy-substituted dihydrobenzopyran-2-carboxylic acids and derivatives thereof'19935,179,123'LTB4 synthesis inhibitors'19935,135,941'LTB.sub.4 synthesis inhibitors'19925,124,350'Leukotriene B.sub.4 antagonists'19925,112,864'PLA.sub.2 inhibitors as antiinflammatories'19925,086,067'LTB.sub.4 synthesis inhibitors'19925,073,562'Alkoxy-substituted dihydrobenzopyran-2-carboxylic acids and derivatives thereof'19915,051,438'Alkoxy-substituted dihydrobenzopyran-2-carboxylic acids and derivatives thereof, compositions and use'19914,971,997'Furyl, phenylene, and thienyl leukotriene B.sub.4 analogues'19904,970,234'Furyl, phenylene, and thienyl leukotriene B.sub.4 analogues'19904,954,520'1,3-dioxolane derivatives useful in the treatment of inflammation'19904,895,869'Phenylene, furyl, and thienyl leukotriene B.sub.4 analogues'19904,889,871'Alkoxy-substituted dihydrobenzopyran-2-carboxylate derivatives'19894,855,324'Furyl, phenylene, and thienyl leukotriene B.sub.4 analogues'19894,791,133'Phenylene, furyl, and thienyl leukotriene B.sub.4 analogues'19884,754,055'Allenic prostacyclins'19884,730,078'Allenic prostacyclins'19884,719,220'15(R)-5-fluoroprostacyclins, pharmaceutical compositions and anti-thrombotic methods of use thereof'19884,687,864'5-fluoro-3-oxa-prostacyclin compounds'19874,628,095'Substituted N-benzyl-4-(benzhydryl) piperidines'19864,616,034'15(R)-5-fluoroprostacyclins, pharmaceutical compositions and anti-thrombotic method of use thereof'19864,579,958'5-fluoro-3-oxa-6,7-didehydro-PGI.sub.1 compounds'1986Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1986–2003Patents assigned to SEARLE & CO (37)· patent assignee history
1986–1988Based in Evanston, IL, US· patent location history
1988–1999Based in Glenview, IL, US· patent location history
1996–2003Based in Malvern, PA, US· patent location history
2000–2018Based in Libertyville, IL, US· patent location history
2001–2012Patents assigned to ABBOTT LAB (13)· patent assignee history
2012–2015Patents assigned to DJURIC STEVAN W (7)· patent assignee history
2013–2019Patents assigned to ABBVIE INC (13)· patent assignee history
2013–2018Patents assigned to ABBVIE DEUTSCHLAND (9)· patent assignee history
2019Based in Lake Bluff, IL, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SEARLE & CO | 37 | 1986–2003 |
| ABBOTT LAB | 13 | 2001–2012 |
| ABBVIE INC | 13 | 2013–2019 |
| ABBVIE DEUTSCHLAND | 9 | 2013–2018 |
| DJURIC STEVAN Wself | 7 | 2012–2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| Libertyville, Illinois, US | 30 | 2000–2018 |
| Glenview, Illinois, US | 26 | 1988–1999 |
| Malvern, Pennsylvania, US | 6 | 1996–2003 |
| Evanston, Illinois, US | 6 | 1986–1988 |
| Lake Bluff, Illinois, US | 1 | 2019 |